Join
Live feed
·
INSIDERFilingvia Quantisnow
Ligand Pharmaceuticals Incorporated logo

Chief Executive Officer Davis Todd C was granted 21,382 shares, increasing direct ownership by 16% to 151,724 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.